BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 9769890)

  • 1. Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
    Nébavi F; Arnavielhe S; Le Guennec R; Ménan E; Kacou A; Combe P; Aoussi E; Mallié M; Koné M; Bastide JM
    Pathol Biol (Paris); 1998 May; 46(5):307-14. PubMed ID: 9769890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
    J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between resistance testing and typing of Candida albicans--isolates from AIDS patients and chronic recurrent oral candidiasis].
    Ruhnke M; Tennagen I; Engelmann E
    Mycoses; 1994; 37 Suppl 1():60-3. PubMed ID: 7854368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro susceptibility of vaginal Candida albicans to antifungal drugs in Abidjan (Ivory Coast)].
    Djohan V; Angora KE; Vanga-Bosson AH; Konaté A; Kassi FK; Yavo W; Kiki-Barro PC; Menan H; Koné M
    J Mycol Med; 2012 Jun; 22(2):129-33. PubMed ID: 23518014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S; Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
    Kutsyk RV; Pavliuk TD
    Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity of Candida strains to polyenic antibiotics in the treatment of oral candidiasis].
    Boĭko GI; Sosnin GP; Adarchenko AA; Moroz GS
    Antibiotiki; 1984 Nov; 29(11):869-72. PubMed ID: 6395795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Yeast infections: causative agents and their antifungal resistance in hospitalized pediatric patients and HIV-positive adults].
    Rodero L; Boutureira M; Demkura H; Burkett A; Fernández C; Losso M; Jáuregui Rueda H; Monticelli A; Vitale R; Canteros C; Hochenfellner F; Vivot W; Davel G
    Rev Argent Microbiol; 1997; 29(1):7-15. PubMed ID: 9229726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of the sensitivity to antifungal agents of clinical isolates of Candida albicans serotype A and B by the ATB Fungus method].
    Quindós G; San Millán R; Burgos A; Lipperheide V; Tellaetxe M; Alonso R; Barturen B; Pontón J
    Enferm Infecc Microbiol Clin; 1995 Apr; 13(4):209-12. PubMed ID: 7779872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between Candida albicans 25S intron genotypes and antifungal susceptibilities].
    Balaban N; Karahan ZC; Mumcuoğlu I; Cayirli A; Kuştimur S
    Mikrobiyol Bul; 2007 Apr; 41(2):245-51. PubMed ID: 17682711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
    Bulacio L; Paz M; Ramadán S; Ramos L; Pairoba C; Sortino M; Escovich L; López C
    J Mycol Med; 2012 Dec; 22(4):348-53. PubMed ID: 23518170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida albicans strain differentiation in complete denture wearers.
    Abu-Elteen KH
    New Microbiol; 2000 Jul; 23(3):329-37. PubMed ID: 10939048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
    Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.
    Liu XP; Fan SR; Bai FY; Li J; Liao QP
    Mycoses; 2009 Jan; 52(1):24-8. PubMed ID: 18498300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral candidiasis in HIV-seropositive patients and AIDS cases. Clinical, mycological and therapeutical aspects].
    Prieto Santa Anna LM; Illnait Zaragozi MT; Ramos Rodallegas EG; Lazcano Herrero B; Márquez Sánchez N; Cantelar de Francisco N; Manzur Katriba J; Martínez Machin G
    Rev Cubana Med Trop; 2006; 58(3):173-80. PubMed ID: 23424783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.